1. Mayer EA, Nance K, Chen S. The gut-brain axis. Annu Rev Med. 2022; 73(1):439-53. doi:10.1146/annurev-med-042320-014032 PMid:34669431

2. Wang Q, Yang Q, Liu X. The microbiota-gut-brain axis and neurodevelopmental disorders. Protein Cell. 2023;14(10):762-75. doi:10.1093/procel/pwad026 PMid:37166201 PMCid:PMC10599644

3. Sharon G, Cruz NJ, Kang DW, Gandal MJ, Wang B, Kim YM, et al. Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice. Cell. 2019;177(6):1600-18.e17. doi:10.1016/j.cell.2019.05.004 PMid:31150625 PMCid:PMC6993574

4. Morais LH, Schreiber HL 4th, Mazmanian SK. The gut microbiota-brain axis in behaviour and brain disorders. Nat Rev Microbiol. 2021;19(4):241-55. doi:10.1038/s41579-020-00460-0 PMid:33093662

5. Nazir MM, Ghaffar W, Mustafa G, Saeed S, Ijaz MU, Ashraf A. Modulating depression through the gut-brain axis: the role of gut microbiota in therapeutic interventions. Naunyn Schmiedebergs Arch Pharmacol. 2025:1-19. doi:10.1007/s00210-025-04464-6 PMid:40690011

6. Liu RT, Walsh RFL, Sheehan AE. Prebiotics and probiotics for depression and anxiety: A systematic review and meta-analysis of controlled clinical trials. Neurosci Biobehav Rev. 2019;102:13-23. doi:10.1016/j.neubiorev.2019.03.023 PMid:31004628 PMCid:PMC6584030

7. Zangeneh Z, Rostamian M, Motamedi H, Alvandi A, Abiri R. The potential effectiveness of probiotics in reducing multiple sclerosis progression in preclinical and clinical studies: A worldwide systematic review and meta-analysis. PLoS One. 2025;20(4):e0319755. doi:10.1371/journal.pone.0319755 PMid:40273120 PMCid:PMC12021188

8. Kleine Bardenhorst S, Cereda E, Severgnini M, Barichella M, Pezzoli G, Keshavarzian A, et al. Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis. Eur J Neurol. 2023; 30(11):3581-94. doi:10.1111/ene.15671 PMid:36593694

9. Gazerani P. Probiotics for Parkinson's Disease. Int J Mol Sci. 2019;20(17):4121. doi:10.3390/ijms20174121 PMid:31450864 PMCid:PMC6747430

10. Parashar A, Udayabanu M. Gut microbiota: Implications in Parkinson's disease. Parkinsonism Relat Disord. 2017;38:1-7. doi:10.1016/j.parkreldis.2017.02.002 PMid:28202372 PMCid:PMC7108450

11. Zarei F, Talebian A, Heydari A, Esmaeiei-Taba SM, Salami M. The effect of probiotic supplementation on drug resistant epilepsy in children. Feyz. 2023;27(2):186-96.

12. Bagheri S, Heidari A, Alinaghipour A, Banitaba SM, Salami M. The effect of probiotics mixture on learning and spatial memory in kindled rats. Feyz. 2018; 22(3):230-8.

13. Mahmoudi H, Hossainpour H. Application and development of fecal microbiota transplantation in the treatment of gastrointestinal and metabolic diseases: A review. Saudi J Gastroenterol. 2023; 29(1): 3-11. doi:10.4103/sjg.sjg_131_22 PMid:36412458 PMCid:PMC10117003

14. Yang J, Liang J, Hu N, He N, Liu B, Liu G, et al. The gut microbiota modulates neuroinflammation in Alzheimer's disease: elucidating crucial factors and mechanistic underpinnings. CNS Neurosci Ther. 2024; 30(10):e70091. doi:10.1111/cns.70091 PMid:39460538 PMCid:PMC11512114

15. Akbari E, Asemi Z, Daneshvar Kakhaki R, Bahmani F, Kouchaki E, Tamtaji OR, et al. Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer's disease: a randomized, double-blind and controlled trial. Front Aging Neurosci. 2016;8:256. doi:10.3389/fnagi.2016.00256 PMid:27891089 PMCid:PMC5105117

16. Castillo-Álvarez F, Marzo-Sola ME. Role of the gut microbiota in the development of various neurological diseases. Neurologia (Engl Ed). 2022; 37(6):492-8. doi:10.1016/j.nrl.2019.03.017

17. Cryan JF, O'Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, et al. The microbiota-gut-brain axis. Physiol Rev. 2019;99(4):1877-2013. doi:10.1152/physrev.00018.2018 PMid:31460832

18. Sampson TR, Mazmanian SK. Control of brain development, function, and behavior by the microbiome. Cell Host Microbe. 2015;17(5):565-76. doi:10.1016/j.chom.2015.04.011 PMid:25974299 PMCid:PMC4442490

19. Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013; 74(10):720-6. doi:10.1016/j.biopsych.2013.05.001 PMid:23759244 PMCid:PMC11788897

20. Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol (Lausanne). 2020; 11:25. doi:10.3389/fendo.2020.00025 PMid:32082260 PMCid:PMC7005631

21. Mörkl S, Butler MI, Holl A, Cryan JF, Dinan TG. Probiotics and the microbiota-gut-brain axis: focus on psychiatry. Curr Nutr Rep. 2020;9(3):171-82. doi:10.1007/s13668-020-00313-5 PMID: 32406013 PMCID: PMC7398953

22. Sandhu KV, Sherwin E, Schellekens H, Stanton C, Dinan TG, Cryan JF. Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry. Transl Res. 2017;179:223-44. doi:10.1016/j.trsl.2016.10.002 PMid:27832936

23. 23. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012; 13(10):701-12. doi:10.1038/nrn3346 PMid:22968153